A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)

Name: A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory T or B Cell Malignancies (COBALT-LYM)
License: Public Domain

CRISPR Therapeutics AG

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

t cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 143561
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.